For the Inventor, By the Inventor

Enter assignee name

Castellbisbal, Spain

Inke, S.a.

Calculating rank

USPTO Granted Patents = 17

% Expired Patents = 41.2

EPO Patents = 11

Forward Citations = 8

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Pere Dalmases Barjoan (13 out of 20 patents)

Joan Huguet Clotet (5 out of 8 patents)

Reyes Herbera Espinal (3 out of 3 patents)

4. Montserrat Armengol Asparo (3 out of 3 patents)

5. Juan Antonio Perez Andres (2 out of 4 patents)

6. Juan Huguet Clotet (2 out of 5 patents)

7. Josep Terradas Camins (1 out of 1 patent)

8. Josep Maria Carulla Oliver (1 out of 1 patent)

9. Silvia Donnici Garcia (1 out of 1 patent)

10. David Gomez Lamarca (1 out of 1 patent)

11. Emma Recio Soler (1 out of 1 patent)

12. Maria Jose Martinez Velon (1 out of 1 patent)

13. Enric Capdevila Urbaneja (1 out of 1 patent)

14. Jordi Bessa Bellmunt (1 out of 3 patents)

15. Noelia Calcerrada Muñoz (1 out of 1 patent)

17 patents: Sort by Forward Citations

1. 12116352 - Process for preparing 1-deoxy-1-methylamino-d-glucitol 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (2024-10-15),

2. 10888500 - Particle size stabilization process (2021-01-12),

3. 10800748 - Process for the manufacture of R-6-hydroxy-8-[1-hydroxy-2-[2-(4-methoxyphenyl)-1,1-dimethylethylaminoethyl]-2H-1,4-benzoxazin-3(4H)-one hydrochloride (2020-10-13),

4. 8309717 - Process to prepare paliperidone and intermediates thereof (2012-11-13),

5. 8304426 - Polymorphic form of Granisetron base, methods for obtaining it and formulation containing it (2012-11-06),

6. 8129522 - Method for preparing a mixed solvate of olanzapine (2012-03-06),

7. 7964749 - Process for obtaining valine derivatives useful for obtaining a pharmaceutically active compound (2011-06-21),

8. 7858821 - Intermediate compounds useful to prepare dolasetron (2010-12-28),

9. 7807827 - Procedure for preparing 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazineyl)-dibenzo[b,f] [1,4]thiazepine (2010-10-05),

10. 7759484 - Mixed solvate of olanzapine, method for preparing it and method for preparing form I of olanzapine therefrom (2010-07-20),

11. 7745628 - Method for obtaining a pharmaceutically active compound, synthesis intermediates thereof and methods for obtaining them (2010-06-29),

12. 7741492 - Method for obtaining a pharmaceutically active compound (Irbesartan) and its synthesis intermediate (2010-06-22),

13. 7728021 - Process for the preparation of Valsartan and precursors thereof (2010-06-01),

14. 7563904 - Synthesis intermediates useful for preparing zolmitriptan (2009-07-21),

15. 7342035 - Process for preparing zolmitriptan compounds (2008-03-11),

Company Overview

Inke, S.a. is a Spanish company based in Castellbisbal, specializing in the development and manufacturing of advanced industrial solutions. The organization focuses on innovative technologies that enhance efficiency and productivity across various sectors. With a commitment to research and development, Inke aims to deliver high-quality products tailored to meet the evolving needs of its clients. Its expertise spans multiple domains, positioning it as a key player in the industrial landscape of Spain and beyond.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

17 Patents

#1 in Castellbisbal

#127 in Spain

#35,974 in the World

Castellbisbal, Spain

Inke, S.a.

Forward Citations = 8

22 inventors:

Pere Dalmases Barjoan (13 out of 20 patents)

Joan Huguet Clotet (5 out of 8 patents)

Reyes Herbera Espinal (3 out of 3 patents)

4. Montserrat Armengol Asparo (3 out of 3 patents)

5. Juan Antonio Perez Andres (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Inke, S.a.. Retrieved from https://idiyas.com/company/inke-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…